文献速递关节外科创伤骨科

感染性全髋关节置换术后行两期翻修术患者失血量巨大

Patients With Infected Total Hip Arthroplasty Undergoing 2-Stage Exchange Arthroplasty Experience Massive Blood Loss.
PubMed 文献 · J Arthroplasty · 2018-07-02

回顾297例1997至2016年因全髋关节置换术后慢性假体周围感染行两期翻修术的患者,再植入期计算失血量5156.0±3402 mL高于切除关节成形术期的3706.9±2148 mL(P<.0001);两期输血率分别为81%和81.1%,第一期为3.6±1.8单位、第二期为4.2±2.9单位(P=.0066);氨甲环酸使用与失血量减少相关。

要点

  • 再植入期计算失血量5156.0±3402 mL,高于切除关节成形术期的3706.9±2148 mL(P<.0001)。
  • 切除关节成形术期输血率81%,再植入期81.1%;平均输血量第一期3.6±1.8单位、第二期4.2±2.9单位(P=.0066)。
  • 氨甲环酸使用与失血量减少相关,作者建议将其更普遍地纳入血液管理方案。

核心结论

  • 全髋关节置换术后假体周围感染患者在两期翻修术的两个阶段均有显著失血,尤其是再植入期。
  • 作者认为,所有第一期后需要输血的患者应考虑血液学优化,因为这些患者在第二期后需要输血的风险更高。
  • 作者认为,氨甲环酸可大幅降低两个阶段需要输血的风险,应更普遍地纳入血液管理方案。

研究设计与样本

  • 回顾性审查1997年至2016年间因感染性全髋关节置换术后行两期翻修术的297例患者的医疗记录。
  • 使用经验证的公式计算失血量,并收集输血数据、临床信息和手术数据以确定失血量和围手术期异体输血的风险因素。

主要发现

  • 再植入期计算失血量5156.0±3402 mL高于切除关节成形术期的3706.9±2148 mL(P<.0001)。
  • 切除关节成形术期输血率为81%,再植入期输血率为81.1%。
  • 异体输血量第一期平均3.6±1.8单位,第二期平均4.2±2.9单位(P=.0066)。
  • 增加围手术期输血可能性的患者特征包括:术前国际标准化比值升高、2型糖尿病、当前吸烟、年龄以及第一期输血需求。
  • 氨甲环酸使用与失血量减少相关。

关键数值与推荐

  • 再植入期计算失血量5156.0±3402 mL vs 切除关节成形术期3706.9±2148 mL(P<.0001)。
  • 切除关节成形术期输血率81%,再植入期输血率81.1%。
  • 异体输血量第一期3.6±1.8单位 vs 第二期4.2±2.9单位(P=.0066)。

临床怎么用

  • 作者认为,所有第一期后需要输血的患者应考虑血液学优化,因为这些患者在第二期后需要输血的风险更高。
  • 作者认为,氨甲环酸可大幅降低两个阶段需要输血的风险,应更普遍地纳入血液管理方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Two-stage exchange arthroplasty is the preferred treatment for chronic periprosthetic joint infection following total hip arthroplasty (THA). These patients are at high risk of substantial blood loss and perioperative blood transfusion. Our study aimed at determining risk factors for blood transfusion during a 2-stage exchange for infected THA. METHODS: Medical records of 297 patients with infected THA who underwent 2-stage exchange arthroplasty from 1997 to 2016 were reviewed. Blood loss was calculated using a validated formula. Transfusion data, clinical information, and operative data were gathered to determine predictors of blood loss and risk factors for perioperative allogeneic blood transfusion. RESULTS: Calculated blood loss was significantly higher during reimplantation than resection arthroplasty (5156.0 ± 3402 mL vs 3706.9 ± 2148 mL; P < .0001). Blood transfusion was needed in 81% after resection and 81.1% after reimplantation. Allogeneic blood transfusion averaged 3.6 ± 1.8 units for stage 1 and 4.2 ± 2.9 units for stage 2 (P = .0066). Patient characteristics that increased the likelihood for perioperative blood transfusions were increasing preoperative international normalized ratio, type 2 diabetes, current smoking, age, and transfusion requirement in the first stage. Tranexamic acid usage was associated with decreased blood loss. CONCLUSION: Patients with periprosthetic joint infection following THA have significant blood loss during both stages of exchange arthroplasty, especially reimplantation. Hematological optimization should be considered in all patients requiring a transfusion after the first stage, as these patients are at greater risk of requiring transfusion after the second stage. The use of tranexamic acid dramatically decreases the risk of requiring a transfusion in both stages and should be more ubiquitously incorporated into blood management protocols.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Goel R, Buckley P, Sterbis E, et al. Patients With Infected Total Hip Arthroplasty Undergoing 2-Stage Exchange Arthroplasty Experience Massive Blood Loss. J Arthroplasty. 2018. PMID: 30100135. doi:10.1016/j.arth.2018.06.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。